Reviewed Mar 2026 | PubMed sources
Active Market
Germany is selected. The evidence comparison is still valid, but provider availability, legal positioning, and cost assumptions may still be staged for later rollout.

AOD-9604 vs Ipamorelin: Head-to-Head Comparison

AOD-9604 is an hGH fragment (176-191) that was designed to isolate fat-burning effects of GH without other GH activity, while ipamorelin stimulates natural GH release for full-spectrum GH benefits. AOD-9604 failed clinical trials for obesity, while ipamorelin shows consistent GH elevation in studies.

Side-by-Side Comparison

DimensionAOD-9604Ipamorelin
Evidence LevelFailed Phase IIb/III trials for obesityPhase II trials showing consistent GH release
FDA StatusNot approvedNot approved
MechanismhGH fragment targeting lipolysis without IGF-1Ghrelin receptor agonist stimulating natural GH pulses
Body Composition EffectFailed to demonstrate efficacy in trialsGH elevation supports fat loss and lean mass
Side EffectsMinimal reportedMinimal; no cortisol/prolactin impact
GH/IGF-1 ImpactDoes not raise GH or IGF-1Raises GH and IGF-1 levels
CostLowModerate
Evidence Level
AOD-9604
Failed Phase IIb/III trials for obesity
Ipamorelin
Phase II trials showing consistent GH release
FDA Status
AOD-9604
Not approved
Ipamorelin
Not approved
Mechanism
AOD-9604
hGH fragment targeting lipolysis without IGF-1
Ipamorelin
Ghrelin receptor agonist stimulating natural GH pulses
Body Composition Effect
AOD-9604
Failed to demonstrate efficacy in trials
Ipamorelin
GH elevation supports fat loss and lean mass
Side Effects
AOD-9604
Minimal reported
Ipamorelin
Minimal; no cortisol/prolactin impact
GH/IGF-1 Impact
AOD-9604
Does not raise GH or IGF-1
Ipamorelin
Raises GH and IGF-1 levels
Cost
AOD-9604
Low
Ipamorelin
Moderate

Peptide Overviews

AOD-9604

CPreclinical

AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) originally developed for obesity treatment. It has been explored as a lipolytic agent in research but has not received FDA approval or GRAS status for any use.

Weight LossNot Approved
View full AOD-9604 profile →

Ipamorelin

BHuman Studies

Ipamorelin is a selective growth hormone secretagogue that stimulates growth hormone release from the pituitary gland without significantly affecting cortisol or prolactin levels.

Growth Hormone SecretagoguesNot Approved
View full Ipamorelin profile →

Supplies for Both

Common research handling and preparation supplies for injectable peptide workflows.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

AOD-9604 vs Ipamorelin: FAQ